Last Updated: September 24, 2026

Patent: 10,507,262

✉ Email this page to a colleague

Summary for Patent: 10,507,262

Title:	Biocompatible hydrogel treatments for retinal detachment
Abstract:	Provided herein are in vivo gelling ophthalmic pre-formulations forming a biocompatible retinal patch comprising at least one nucleophilic compound or monomer unit, at least one electrophilic compound or monomer unit, and optionally a therapeutic agent and/or viscosity enhancer. In some embodiments, the retinal patch at least partially adheres to the site of a retinal tear. Also provided herein are methods of treating retinal detachment by delivering an in vivo gelling ophthalmic pre-formulation to the site of a retinal tear in human eye, wherein the in vivo gelling ophthalmic pre-formulation forms a retinal patch.
Inventor(s):	Askari; Syed H. (San Jose, CA), Choi; Yeon S. (Emeryville, CA)
Assignee:	C.P. MEDICAL CORPORATION (Norcross, GA)
Application Number:	15/467,019
Patent Claims:	see list of patent claims

Details for Patent 10,507,262

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Genentech, Inc.	RITUXAN	rituximab	Injection	103705	26-Nov-97	⤷ Start Trial	2037-03-23
Hoffmann-la Roche Inc.	ZENAPAX	daclizumab	Injection	103749	10-Dec-97	⤷ Start Trial	2037-03-23
Novartis Pharmaceuticals Corporation	SIMULECT	basiliximab	For Injection	103764	12-May-98	⤷ Start Trial	2037-03-23
Novartis Pharmaceuticals Corporation	SIMULECT	basiliximab	For Injection	103764	2-Jan-03	⤷ Start Trial	2037-03-23
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.